BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 37781361)

  • 1. Rare solid tumors in a patient with Wiskott-Aldrich syndrome after hematopoietic stem cell transplantation: case report and review of literature.
    Coppola E; Giardino G; Abate M; Tambaro FP; Bifano D; Toriello E; De Rosa A; Cillo F; Pignata C; Cirillo E
    Front Immunol; 2023; 14():1229674. PubMed ID: 37781361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lentiviral haemopoietic stem/progenitor cell gene therapy for treatment of Wiskott-Aldrich syndrome: interim results of a non-randomised, open-label, phase 1/2 clinical study.
    Ferrua F; Cicalese MP; Galimberti S; Giannelli S; Dionisio F; Barzaghi F; Migliavacca M; Bernardo ME; Calbi V; Assanelli AA; Facchini M; Fossati C; Albertazzi E; Scaramuzza S; Brigida I; Scala S; Basso-Ricci L; Pajno R; Casiraghi M; Canarutto D; Salerio FA; Albert MH; Bartoli A; Wolf HM; Fiori R; Silvani P; Gattillo S; Villa A; Biasco L; Dott C; Culme-Seymour EJ; van Rossem K; Atkinson G; Valsecchi MG; Roncarolo MG; Ciceri F; Naldini L; Aiuti A
    Lancet Haematol; 2019 May; 6(5):e239-e253. PubMed ID: 30981783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haploidentical bone marrow transplantation in a pediatric patient with Wiskott-Aldrich syndrome. A case report.
    Pury S; López Orozco M; Pichichero G; Sasia LV; Morell D; Álvarez MS; Basquiera AL; Mas ME; Salvucci K
    Arch Argent Pediatr; 2024 Feb; 122(1):e202310061. PubMed ID: 37471507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stable mixed chimerism after hematopoietic stem cell transplantation in Wiskott-Aldrich syndrome.
    Doğu F; Kurtuluş-Ulküer M; Bilge Y; Bozdoğan G; Ulküer U; Malhatun E; Ikincioğullari A; Babacan E
    Pediatr Transplant; 2006 May; 10(3):395-9. PubMed ID: 16677369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes after Allogeneic Transplant in Patients with Wiskott-Aldrich Syndrome.
    Ngwube A; Hanson IC; Orange J; Rider NL; Seeborg F; Shearer W; Noroski L; Nicholas S; Forbes L; Leung K; Sasa G; Naik S; Hegde M; Omer B; Ahmed N; Allen C; Gottschalk S; Wu MF; Liu H; Brenner M; Heslop H; Krance R; Martinez C
    Biol Blood Marrow Transplant; 2018 Mar; 24(3):537-541. PubMed ID: 29196075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hematopoietic stem cell transplantation for Wiskott-Aldrich syndrome: an EBMT Inborn Errors Working Party analysis.
    Albert MH; Slatter MA; Gennery AR; Güngör T; Bakunina K; Markovitch B; Hazelaar S; Sirait T; Courteille V; Aiuti A; Aleinikova OV; Balashov D; Bernardo ME; Bodova I; Bruno B; Cavazzana M; Chiesa R; Fischer A; Hauck F; Ifversen M; Kałwak K; Klein C; Kulagin A; Kupesiz A; Kuskonmaz B; Lindemans CA; Locatelli F; Lum SH; Maschan A; Meisel R; Moshous D; Porta F; Sauer MG; Sedlacek P; Schulz A; Suarez F; Vallée TC; Winiarski JH; Zecca M; Neven B; Veys P; Lankester AC
    Blood; 2022 Mar; 139(13):2066-2079. PubMed ID: 35100336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical, Laboratory Features and Clinical Courses of Patients with Wiskott Aldrich Syndrome and X-linked Thrombocytopenia-A single center study.
    Bildik HN; Cagdas D; Ozturk Kura A; Oskay Halacli S; Sanal O; Tezcan I
    Immunol Invest; 2022 Jul; 51(5):1272-1283. PubMed ID: 34098853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current and emerging treatment options for Wiskott-Aldrich syndrome.
    Worth AJ; Thrasher AJ
    Expert Rev Clin Immunol; 2015; 11(9):1015-32. PubMed ID: 26159751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wiskott Aldrich Syndrome: A Multi-Institutional Experience From India.
    Suri D; Rikhi R; Jindal AK; Rawat A; Sudhakar M; Vignesh P; Gupta A; Kaur A; Sharma J; Ahluwalia J; Bhatia P; Khadwal A; Raj R; Uppuluri R; Desai M; Taur P; Pandrowala AA; Gowri V; Madkaikar MR; Lashkari HP; Bhattad S; Kumar H; Verma S; Imai K; Nonoyama S; Ohara O; Chan KW; Lee PP; Lau YL; Singh S
    Front Immunol; 2021; 12():627651. PubMed ID: 33936041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes following gene therapy in patients with severe Wiskott-Aldrich syndrome.
    Hacein-Bey Abina S; Gaspar HB; Blondeau J; Caccavelli L; Charrier S; Buckland K; Picard C; Six E; Himoudi N; Gilmour K; McNicol AM; Hara H; Xu-Bayford J; Rivat C; Touzot F; Mavilio F; Lim A; Treluyer JM; Héritier S; Lefrère F; Magalon J; Pengue-Koyi I; Honnet G; Blanche S; Sherman EA; Male F; Berry C; Malani N; Bushman FD; Fischer A; Thrasher AJ; Galy A; Cavazzana M
    JAMA; 2015 Apr; 313(15):1550-63. PubMed ID: 25898053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. When
    Jin YY; Wu J; Chen TX; Chen J
    Front Immunol; 2019; 10():1549. PubMed ID: 31354712
    [No Abstract]   [Full Text] [Related]  

  • 12. Successful Reduced Intensity Allogeneic Transplant With Full Donor Chimerism and Good Quality of Life in Adolescent Patient With Wiskott-Aldrich Syndrome.
    Ali S; Gacsadi A; McDougall E; Armstrong C; Krueger J; Schechter T; Ali M
    J Pediatr Hematol Oncol; 2017 Jul; 39(5):e267-e269. PubMed ID: 28538502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The usefulness of X-linked polymorphic loci as gene markers to track X allele and chimerism in a post-allogeneic peripheral blood stem cell transplant patient with Wiskott-Aldrich syndrome.
    Sasanakul W; Hongeng S; Chuansumrit A; Chaiyaratana W; Pakakasama S; Hathirat P
    J Med Assoc Thai; 2001 Mar; 84(3):379-84. PubMed ID: 11460939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical features and genotype analysis of 132 patients with Wiskott-Aldrich syndrome].
    Li W; Liu D; Zhang X; Ding Y; Zhao X
    Zhonghua Er Ke Za Zhi; 2015 Dec; 53(12):925-30. PubMed ID: 26887548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wiskott-Aldrich syndrome: diagnosis, clinical and laboratory manifestations, and treatment.
    Ochs HD; Filipovich AH; Veys P; Cowan MJ; Kapoor N
    Biol Blood Marrow Transplant; 2009 Jan; 15(1 Suppl):84-90. PubMed ID: 19147084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CMV Retinitis in Wiskott Aldrich Syndrome.
    Luo J; Peng J; Zhao PQ; Fei P
    Ocul Immunol Inflamm; 2023 Jan; 31(1):134-141. PubMed ID: 34878956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hematopoietic stem cell transplantation for patients with Wiskott-Aldrich syndrome].
    Wietstruck P MA; Zúñiga C P; Talesnik G E; Méndez R C; Barriga C F
    Rev Med Chil; 2007 Jul; 135(7):917-23. PubMed ID: 17914550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Phenotype and Treatment of WIP Deficiency: Literature Synopsis and Review of a Patient With Pre-transplant Serial Donor Lymphocyte Infusions to Eliminate CMV.
    Schwinger W; Urban C; Ulreich R; Sperl D; Karastaneva A; Strenger V; Lackner H; Boztug K; Albert MH; Benesch M; Seidel MG
    Front Immunol; 2018; 9():2554. PubMed ID: 30450104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Confirmed diagnosis of classic Wiskott-Aldrich syndrome in East Africa: a case report.
    Kiputa M; Urio O; Maghembe A; Kombo D; Dhalla S; Ndembo V; Muze K; Kahwa M; Fakih Z; Kija E
    J Med Case Rep; 2022 Jul; 16(1):301. PubMed ID: 35897083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and genetic analysis of 2 rare cases of Wiskott-Aldrich syndrome from Chinese minorities: Two case reports.
    Liu H; Wang Y; Li Y; Tao L; Zhang Y; He X; Zhou Y; Liu X; Wang Y; Li L
    Medicine (Baltimore); 2021 Apr; 100(16):e25527. PubMed ID: 33879693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.